Finding Needles in a Haystack: How One Lab Identified Random Errors in a Large Dataset
|
By Jen A. Miller (AACC) Posted on 07 Jul 2023 |

Illustration
Lab errors are bound to happen. A mishandled sample here, an equipment failure there—they’re usually not a big deal to fix. But infrequent random errors, especially in high-volume automated tests, can be challenging for clinical laboratorians to identify and rectify in real time. Yet doing so is critical because these problems affect patient care, over and over again.
“As much as we like to believe that errors should not occur in the clinical laboratory, they can and they do,” said Clarence Chan, MD, PhD, a clinical chemistry fellow in the department of pathology at the University of Chicago. “It’s important that we have a rational and objective approach to dealing with these kinds of situations.”
During a roundtable session at the upcoming 2023 AACC Annual Scientific Meeting & Clinical Lab Expo, Chan will present a case study about how his team discovered and investigated random errors that were reoccuring over time. He described the errors as hard to catch even though the lab had quality-control measures in place.
“That’s the whole point of quality control, but sometimes the errors are so sporadic that you don’t always see them,” Chan said. “By coincidence, we had a few primary care doctors asking us about [a couple of results].” That kicked off an investigation into what could be causing such odd and seemingly random recurring errors.
Chan said this case is unique because of its scope–the team reviewed more than 11,000 results over a fairly long period of time–and because it required them to identify a very small fraction of spurious results within that large group. While the details of his experience won’t universally apply to other labs, he hopes participants can learn from how they solved the mystery. This process included brainstorming possible issues and systemically investigating each one until they found the root cause.
Another way labs can benefit from Chan’s insights is hearing how the team applied tools like data analysis and data informatics to their investigation.
“The goal is not to give someone an exact prescription or algorithm of how you deal with these scenarios,” he said. “Every situation will be different.” He added that his team didn’t need high-tech tools to unlock their error-causing mystery. In fact, one of the most important pieces of software they used was Microsoft Excel. “We didn’t have to do any hardcore programming, even though we handle large volumes of data. Understanding how to effectively use Excel, while also recognizing its limits and pitfalls, can also help develop an approach for using more conventional programming software such as R and Python” he said.
The roundtable will empower laboratorians with little to no prior experience in data analytics to gain confidence using large datasets in today’s increasingly digitized healthcare system. This skill is becoming even more critical, given trends towards collecting and analyzing more data across healthcare settings, including clinical laboratories. Globally, “there’s been this push for how do we get that information more efficiently and make more out of it. We’re turning out patient results all the time,” he said. “Not only are you ensuring they're accurate and precise from a technical standpoint, but when there are questions about when things go wrong, how do we get the relevant information?”
“As much as we like to believe that errors should not occur in the clinical laboratory, they can and they do,” said Clarence Chan, MD, PhD, a clinical chemistry fellow in the department of pathology at the University of Chicago. “It’s important that we have a rational and objective approach to dealing with these kinds of situations.”
During a roundtable session at the upcoming 2023 AACC Annual Scientific Meeting & Clinical Lab Expo, Chan will present a case study about how his team discovered and investigated random errors that were reoccuring over time. He described the errors as hard to catch even though the lab had quality-control measures in place.
“That’s the whole point of quality control, but sometimes the errors are so sporadic that you don’t always see them,” Chan said. “By coincidence, we had a few primary care doctors asking us about [a couple of results].” That kicked off an investigation into what could be causing such odd and seemingly random recurring errors.
Chan said this case is unique because of its scope–the team reviewed more than 11,000 results over a fairly long period of time–and because it required them to identify a very small fraction of spurious results within that large group. While the details of his experience won’t universally apply to other labs, he hopes participants can learn from how they solved the mystery. This process included brainstorming possible issues and systemically investigating each one until they found the root cause.
Another way labs can benefit from Chan’s insights is hearing how the team applied tools like data analysis and data informatics to their investigation.
“The goal is not to give someone an exact prescription or algorithm of how you deal with these scenarios,” he said. “Every situation will be different.” He added that his team didn’t need high-tech tools to unlock their error-causing mystery. In fact, one of the most important pieces of software they used was Microsoft Excel. “We didn’t have to do any hardcore programming, even though we handle large volumes of data. Understanding how to effectively use Excel, while also recognizing its limits and pitfalls, can also help develop an approach for using more conventional programming software such as R and Python” he said.
The roundtable will empower laboratorians with little to no prior experience in data analytics to gain confidence using large datasets in today’s increasingly digitized healthcare system. This skill is becoming even more critical, given trends towards collecting and analyzing more data across healthcare settings, including clinical laboratories. Globally, “there’s been this push for how do we get that information more efficiently and make more out of it. We’re turning out patient results all the time,” he said. “Not only are you ensuring they're accurate and precise from a technical standpoint, but when there are questions about when things go wrong, how do we get the relevant information?”
Latest AACC 2023 News
- First-of-Its-Kind Single-Cell Clinical Microbiology Platform Wins 2023 Disruptive Technology Award
- Ground-Breaking Phage-Based Diagnostic Kit for Laboratory Tuberculosis Testing Presented at AACC 2023
- Laboratory Experts Show How They Are Leading the Way on Global Trends
- Unique Competition Focuses on Using Data Science to Forecast Preanalytical Errors
- Best Approach to Infectious Disease Serology Testing for Laboratorians and Clinicians Discussed at AACC 2023
- Breaking Research Throws Light on COVID, Flu, and RSV Co-Infections
- New Research Shows Self-Collected Tests Perform Similarly to Provider-Collected Tests for Detecting STIs
- AI Predicts Multiple Sclerosis Risk, Flags Potentially Contaminated Lab Results
- Scientific Session Explores Role of Technology in New Era of Specimen Transport
- Prevencio Presents AI-Driven Platform for Medical Diagnostic Test Development
- Scientific Session Explores Future Role of AI and ML in Clinical Laboratory
- SARSTEDT Demonstrates Pre-Analytic Innovations for Improving Specimen Quality, Reducing TAT and Automating Labs
- World's First Large Sample Volume, Open-Assay, Super-fast, Ultra-Sensitive, and Sample-To-Answer PCR Instrument
- Vital Biosciences Unveils Revolutionary POC Lab Testing Platform
- World's Smallest POC Device for Complete Blood Count in 30 Minutes Unveiled
- General Biologicals Unveils CTC Cancer Detection Products and Automated Molecular System
Channels
Clinical Chemistry
view channel
Screening After Pneumococcal Disease May Reveal Undiagnosed Blood Cancer or Immune Disorders
Severe pneumococcal disease requiring hospitalization often presents as pneumonia, particularly in older adults and people with cancer or compromised immune function. Because M protein testing and antibody... Read more
Global Survey Underscores Need to Standardize Bone Biomarker Testing
Bone and mineral metabolism biomarkers can complement dual-energy X-ray absorptiometry (DXA) by providing information on disease activity and treatment response. For more than 20 years, standardization... Read more
Label-Free Platform Combines Microfluidics and AI for Circulating Tumor Cell Analysis
Liquid biopsy relies on detecting rare tumor-derived material in blood, but circulating tumor cells (CTCs) are especially difficult to capture because they are vastly outnumbered by normal blood cells.... Read more
Rapid D-Dimer Assay Supports Exclusion and Monitoring of Serious Clotting Conditions
Blood clots can rapidly become life‑threatening and affect approximately 10 million people worldwide each year. During time‑sensitive evaluations, clinicians use D‑dimer testing to help rule out deep vein... Read moreMolecular Diagnostics
view channel
Facilitated Cascade Program Increases Genetic Testing in Hereditary Cancer Families
Hereditary cancer risk can extend beyond an individual patient to parents, siblings, and children. Although BRCA1 and BRCA2 mutations are linked to elevated risks of breast, ovarian, prostate, and other... Read more
Urine-Based RNA Improves Bladder Cancer Detection and Monitoring
Bladder cancer affects about 85,000 people in the United States each year and is prone to recurrence. Diagnosis and surveillance commonly rely on cystoscopy, an endoscopic examination that can miss up... Read moreHematology
view channel
New Donor Genetic Marker May Help Predict Stem Cell Transplant Success
Donor selection for hematopoietic stem cell transplantation plays a major role in relapse risk and survival for patients with blood cancers and other blood disorders. Despite advances in genotyping, uncertainty... Read more
Updated Ferritin Thresholds Improve Detection of Iron Deficiency
Iron deficiency is one of the most common health conditions worldwide, yet its nonspecific symptoms can delay diagnosis for months. Variation in testing practices and ferritin thresholds may contribute... Read moreImmunology
view channel
Routine Newborn Blood Spots Can Measure GBS Antibody Levels
Group B Streptococcus (GBS) can cause serious infections in newborns. Protecting infants remains challenging because immune protection may depend on antibodies transferred from mother to baby before birth.... Read more
Blood Test Differentiates Bacterial and Viral Infections in Febrile Infants
Fever in infants younger than 3 months is treated as a medical emergency because infections can become life-threatening while the immune system is still developing. Emergency department teams must quickly... Read moreMicrobiology
view channel
FDA-Cleared Multiplex PCR Test Detects 13 Respiratory Pathogens in a Single Sample
Respiratory tract infections can be difficult to distinguish at presentation because many cause overlapping, nonspecific symptoms and are initially grouped as influenza-like illnesses. Causes span a range... Read more
One-Hour Molecular Panel Expands Bloodstream Infection Testing for Gram-Negative Pathogens
Bloodstream infections can progress rapidly and lead to sepsis, organ failure, and death. In the United States, about 1.7 million adults develop sepsis each year, and at least 350,000 die during hospitalization... Read more
FDA Clears Rapid Phenotypic Antimicrobial Susceptibility System for Positive Blood Cultures
Bloodstream infections require prompt treatment, but antimicrobial susceptibility results often lag behind a positive blood culture. Conventional testing can take another 24 to 48 hours after a culture... Read more
New Urine Test Expands Mycotoxin Analysis to 31 Markers for Broader Exposure Assessment
Clinical evaluation of mold exposure increasingly relies on urinary mycotoxin testing, but limited marker coverage and metabolite masking can make results more difficult to interpret. Broader analysis... Read morePathology
view channel
Rapid Mass Spectrometry Test May Aid Glioma Margin Decisions
Glioma brain tumors are highly infiltrative and can extend into nearby healthy brain tissue, making tumor margins difficult to define during surgery. Residual tumor cells may contribute to recurrence and... Read more
Genomic Classifier Predicts Benefit From Adding Hormone Therapy to Salvage Prostate Radiation
Men who have undergone prostatectomy for prostate cancer may later develop a detectable or rising prostate-specific antigen, prompting salvage radiation therapy. A key challenge is determining who is most... Read moreTechnology
view channelLaser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns
Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more
Laser-Enhanced Assay Boosts Sensitivity for Colorectal Cancer Biomarker Detection
Colorectal cancer is the third most commonly diagnosed cancer and the second leading cause of cancer-related death worldwide. Early detection remains critical, but cancer biomarkers can produce only faint... Read moreIndustry
view channel
Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection
Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Mayo Clinic Laboratories and Pathology Asia Expand Genomic Testing Across Asia-Pacific
Mayo Clinic Laboratories and Pathology Asia Holdings (PAH), together with subsidiary LifeStrands Genomics, announced a strategic investment and collaboration focused on expanding access to advanced diagnostics... Read more








